US Stock MarketDetailed Quotes

VANI Vivani Medical

Watchlist

1.260
-0.030-2.33%

Close Nov 4 16:00 ET

1.260
0.0000.00%

Post 20:02 ET

69.62MMarket Cap-2739P/E (TTM)

Vivani Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

13.50%-4.8M

35.23%-4.51M

-26.15%-23.7M

33.10%-3.48M

-10.68%-7.7M

-60.92%-5.55M

-119.33%-6.97M

-71.56%-18.79M

-75.84%-5.2M

-6.96M

Net income from continuing operations

17.93%-5.36M

4.42%-6.04M

-84.69%-25.65M

17.27%-6.03M

-576.60%-6.78M

-59.02%-6.53M

-61.01%-6.32M

-8.74%-13.89M

-101.22%-7.28M

--1.42M

Operating gains losses

----

--121K

----

Depreciation and amortization

25.00%100K

-8.33%99K

-6.30%357K

-10.91%98K

-29.70%71K

-8.05%80K

30.12%108K

10.43%381K

32.53%110K

--101K

Other non cash items

-61.58%73K

232.26%82K

113.08%904K

227.12%75K

110.15%701K

603.70%190K

-329.63%-62K

-1,002.55%-6.91M

-326.92%-59K

---6.91M

Change In working capital

-119.23%-35K

193.41%993K

-482.54%-1.29M

-3.66%1.79M

-12.05%-2.2M

23.81%182K

-456.71%-1.06M

-22.48%338K

1,488.89%1.86M

---1.97M

-Change in prepaid assets

140.11%448K

463.40%556K

155.46%264K

1,023.42%3.55M

-229.95%-2.02M

-830.83%-1.12M

-150.82%-153K

-566.67%-476K

364.71%316K

---611K

-Change in payables and accrued expense

-137.18%-483K

148.02%437K

-291.28%-1.56M

-214.00%-1.76M

86.20%-187K

386.52%1.3M

-353.48%-910K

143.71%814K

3,048.98%1.54M

---1.36M

Cash from discontinued investing activities

Operating cash flow

13.50%-4.8M

35.23%-4.51M

-26.15%-23.7M

33.10%-3.48M

-10.68%-7.7M

-60.92%-5.55M

-119.33%-6.97M

-71.56%-18.79M

-75.84%-5.2M

---6.96M

Investing cash flow

Cash flow from continuing investing activities

15.91%-37K

-391.89%-182K

-162.43%-887K

-1,712.20%-743K

65.19%-63K

48.84%-44K

-23.33%-37K

40.91%-338K

83.98%-41K

-181K

Net PPE purchase and sale

15.91%-37K

-391.89%-182K

-162.43%-887K

-734.83%-743K

52.63%-63K

48.84%-44K

-23.33%-37K

40.91%-338K

65.23%-89K

---133K

Cash from discontinued investing activities

Investing cash flow

15.91%-37K

-391.89%-182K

-162.43%-887K

-1,712.20%-743K

65.19%-63K

48.84%-44K

-23.33%-37K

40.91%-338K

83.98%-41K

---181K

Financing cash flow

Cash flow from continuing financing activities

1,457.14%109K

13.69M

-99.79%133K

23K

-99.81%103K

-41.67%7K

445.52%63.39M

55.38M

Net common stock issuance

--112K

--13.69M

731.25%133K

----

--0

-99.86%16K

----

Proceeds from stock option exercised by employees

-142.86%-3K

--3K

----

--103K

--7K

--0

----

Net other financing activities

----

--63.37M

--0

--55.37M

Cash from discontinued financing activities

Financing cash flow

1,457.14%109K

--13.69M

-99.79%133K

--23K

-99.81%103K

-41.67%7K

--0

445.52%63.39M

--0

--55.38M

Net cash flow

Beginning cash position

-21.43%30.99M

-52.65%21.99M

2,032.32%46.44M

-49.33%26.19M

881.22%33.85M

465.60%39.44M

2,032.32%46.44M

4.66%2.18M

4,294.90%51.68M

--3.45M

Current changes in cash

15.36%-4.73M

228.46%9M

-155.24%-24.45M

19.89%-4.2M

-115.88%-7.66M

-58.59%-5.59M

-246.05%-7M

45,534.02%44.27M

-623.35%-5.24M

--48.24M

Effect of exchange rate changes

--0

---2K

400.00%3K

200.00%6K

0.00%-3K

--0

---1K

--2K

---3K

End cash Position

-22.44%26.26M

-21.43%30.99M

-52.65%21.99M

-49.33%26.19M

881.22%33.85M

465.60%39.44M

2,032.32%46.44M

--51.68M

Free cash flow

13.51%-4.84M

32.97%-4.69M

-28.55%-24.59M

19.45%-4.22M

-8.75%-7.77M

-58.25%-5.59M

-118.43%-7M

-65.97%-19.13M

-63.11%-5.24M

---7.14M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	13.50%-4.8M	35.23%-4.51M	-26.15%-23.7M	33.10%-3.48M	-10.68%-7.7M	-60.92%-5.55M	-119.33%-6.97M	-71.56%-18.79M	-75.84%-5.2M	-6.96M
Net income from continuing operations	17.93%-5.36M	4.42%-6.04M	-84.69%-25.65M	17.27%-6.03M	-576.60%-6.78M	-59.02%-6.53M	-61.01%-6.32M	-8.74%-13.89M	-101.22%-7.28M	--1.42M
Operating gains losses	----	----	--121K	----	----	----	----	----	----	----
Depreciation and amortization	25.00%100K	-8.33%99K	-6.30%357K	-10.91%98K	-29.70%71K	-8.05%80K	30.12%108K	10.43%381K	32.53%110K	--101K
Other non cash items	-61.58%73K	232.26%82K	113.08%904K	227.12%75K	110.15%701K	603.70%190K	-329.63%-62K	-1,002.55%-6.91M	-326.92%-59K	---6.91M
Change In working capital	-119.23%-35K	193.41%993K	-482.54%-1.29M	-3.66%1.79M	-12.05%-2.2M	23.81%182K	-456.71%-1.06M	-22.48%338K	1,488.89%1.86M	---1.97M
-Change in prepaid assets	140.11%448K	463.40%556K	155.46%264K	1,023.42%3.55M	-229.95%-2.02M	-830.83%-1.12M	-150.82%-153K	-566.67%-476K	364.71%316K	---611K
-Change in payables and accrued expense	-137.18%-483K	148.02%437K	-291.28%-1.56M	-214.00%-1.76M	86.20%-187K	386.52%1.3M	-353.48%-910K	143.71%814K	3,048.98%1.54M	---1.36M
Cash from discontinued investing activities
Operating cash flow	13.50%-4.8M	35.23%-4.51M	-26.15%-23.7M	33.10%-3.48M	-10.68%-7.7M	-60.92%-5.55M	-119.33%-6.97M	-71.56%-18.79M	-75.84%-5.2M	---6.96M
Investing cash flow
Cash flow from continuing investing activities	15.91%-37K	-391.89%-182K	-162.43%-887K	-1,712.20%-743K	65.19%-63K	48.84%-44K	-23.33%-37K	40.91%-338K	83.98%-41K	-181K
Net PPE purchase and sale	15.91%-37K	-391.89%-182K	-162.43%-887K	-734.83%-743K	52.63%-63K	48.84%-44K	-23.33%-37K	40.91%-338K	65.23%-89K	---133K
Cash from discontinued investing activities
Investing cash flow	15.91%-37K	-391.89%-182K	-162.43%-887K	-1,712.20%-743K	65.19%-63K	48.84%-44K	-23.33%-37K	40.91%-338K	83.98%-41K	---181K
Financing cash flow
Cash flow from continuing financing activities	1,457.14%109K	13.69M	-99.79%133K	23K	-99.81%103K	-41.67%7K	0	445.52%63.39M	0	55.38M
Net common stock issuance	--112K	--13.69M	731.25%133K	----	----	--0	--0	-99.86%16K	----	----
Proceeds from stock option exercised by employees	-142.86%-3K	--3K	----	----	--103K	--7K	--0	----	----	----
Net other financing activities	----	----	----	----	----	----	----	--63.37M	--0	--55.37M
Cash from discontinued financing activities
Financing cash flow	1,457.14%109K	--13.69M	-99.79%133K	--23K	-99.81%103K	-41.67%7K	--0	445.52%63.39M	--0	--55.38M
Net cash flow
Beginning cash position	-21.43%30.99M	-52.65%21.99M	2,032.32%46.44M	-49.33%26.19M	881.22%33.85M	465.60%39.44M	2,032.32%46.44M	4.66%2.18M	4,294.90%51.68M	--3.45M
Current changes in cash	15.36%-4.73M	228.46%9M	-155.24%-24.45M	19.89%-4.2M	-115.88%-7.66M	-58.59%-5.59M	-246.05%-7M	45,534.02%44.27M	-623.35%-5.24M	--48.24M
Effect of exchange rate changes	--0	---2K	400.00%3K	200.00%6K	0.00%-3K	--0	--0	---1K	--2K	---3K
End cash Position	-22.44%26.26M	-21.43%30.99M	-52.65%21.99M	-52.65%21.99M	-49.33%26.19M	881.22%33.85M	465.60%39.44M	2,032.32%46.44M	2,032.32%46.44M	--51.68M
Free cash flow	13.51%-4.84M	32.97%-4.69M	-28.55%-24.59M	19.45%-4.22M	-8.75%-7.77M	-58.25%-5.59M	-118.43%-7M	-65.97%-19.13M	-63.11%-5.24M	---7.14M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data